Healthcare Providers and Services
Company Overview of Hadassah Medical Organisation (HMO)
Hadassah Medical Organization (HMO) is a medical and research institution that operates Hadassah University Hospitals at Ein Kerem and Mt. Scopus and associated outpatient and day-care services. The company also owns Hadassah Community Health Center in Kiryat Hayovel, which provides clinical care and serves as a demonstration center for new programs in primary care, family medicine, mother and child health, and public health. HMO has four departments: Osteoporosis Institute, Early Detection of Malignancies, Dietetic Service, and Center for Complementary (Integrative) Medicine. HMO was founded in 1912 and is headquartered in Jerusalem, Israel.
Founded in 1912
Key Executives for Hadassah Medical Organisation (HMO)
Head of Bone Marrow Transplantation
Compensation as of Fiscal Year 2014.
Hadassah Medical Organisation (HMO) Key Developments
Hadassah Medical Center Announces Management Changes
Jun 9 14
Avigdor Kaplan is stepping down as CEO of Hadassah Medical Center. Prof. Tamar Peretz will fill the CEO role for the time being. Tamar Peretz is head of Haddasah's Sharett Institute of Oncology. Kaplan said that he could not accept the agreement between the Hadassah organization and the Finance and Health ministries that for the duration of the seven year period of the hospital's recovery plan, a supervisory financial controller would be appointed on behalf of the state.
Staff at Hadassah Medical Centre Begins an Open-Ended Strike
Feb 10 14
More than 6,000 staff at Hadassah medical centre began an open-ended strike on February 10, 2014 over a salary cut, halting all operations except emergency care. Last week the hospital's 850 doctors began a strike after only receiving half of their January salary and on February 9, 2014 all Israeli hospitals joined them in a two-hour solidarity strike. The strike expanded on February 10, 2014 with all of the staff at Hadassah Ein Kerem and Hadassah Mt Scopus joining the protest.
Hadassah Medical Organization Signs $4 Million License and Cooperation Agreement with Synektik SA
Nov 19 13
Hadassah Medical Organization has signed a $4 million license and cooperation agreement with Synektik SA to develop new imaging agents for non-invasive diagnosis of cardiovascular diseases. Synektik will finance research and pre-clinical development of the imaging agents over a period of three years, followed by possible milestone payments and royalties. In return, Synektik receives a worldwide license to the newly developed imaging agents and will lead further development, the clinical trials registration and commercialization. The technology is based on a new agent for use in PET/CT scans, which enables a quantitative measurement of blood flow to the heart. This marker also enables doctors to make a qualitative analysis of damage caused after a heart attack, and predict the degree of recovery for the heart after a heart attack or bypass surgery. Implementing the application of this newly-identified marker to diagnose patients with coronary artery diseases could facilitate more accurate diagnoses and treatment methods. The research will be conducted in the Cyclotron and Radiochemistry Unit in Hadassah Hospital Ein Kerem in cooperation with the Synektik's new R&D facility in Warsaw.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries